BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7738180)

  • 1. Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study.
    Lafage MH; Balena R; Battle MA; Shea M; Seedor JG; Klein H; Hayes WC; Rodan GA
    J Clin Invest; 1995 May; 95(5):2127-33. PubMed ID: 7738180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
    Balena R; Toolan BC; Shea M; Markatos A; Myers ER; Lee SC; Opas EE; Seedor JG; Klein H; Frankenfield D
    J Clin Invest; 1993 Dec; 92(6):2577-86. PubMed ID: 8254015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle X-ray scattering and backscattered electron imaging study.
    Fratzl P; Schreiber S; Roschger P; Lafage MH; Rodan G; Klaushofer K
    J Bone Miner Res; 1996 Feb; 11(2):248-53. PubMed ID: 8822349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs.
    Roschger P; Fratzl P; Klaushofer K; Rodan G
    Bone; 1997 May; 20(5):393-7. PubMed ID: 9145235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae.
    Balena R; Markatos A; Seedor JG; Gentile M; Stark C; Peter CP; Rodan GA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):277-83. PubMed ID: 8558443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
    Allen MR; Iwata K; Phipps R; Burr DB
    Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety of the aminobisphosphonate alendronate in adult dogs. I. General safety and biomechanical properties of bone.
    Peter CP; Guy J; Shea M; Bagdon W; Kline WF; Hayes WC
    J Pharmacol Exp Ther; 1996 Jan; 276(1):271-6. PubMed ID: 8558442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bisphosphonates on matrix mineralization.
    Boivin G; Meunier PJ
    J Musculoskelet Neuronal Interact; 2002 Dec; 2(6):538-43. PubMed ID: 15758388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onion decreases the ovariectomy-induced osteopenia in young adult rats.
    Huang TH; Mühlbauer RC; Tang CH; Chen HI; Chang GL; Huang YW; Lai YT; Lin HS; Yang WT; Yang RS
    Bone; 2008 Jun; 42(6):1154-63. PubMed ID: 18387868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
    Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
    Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
    J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
    Søgaard CH; Mosekilde L; Richards A; Mosekilde L
    Ugeskr Laeger; 1995 Apr; 157(14):2004-8. PubMed ID: 7740640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
    Chavassieux PM; Arlot ME; Reda C; Wei L; Yates AJ; Meunier PJ
    J Clin Invest; 1997 Sep; 100(6):1475-80. PubMed ID: 9294113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats.
    Azuma Y; Oue Y; Kanatani H; Ohta T; Kiyoki M; Komoriya K
    J Pharmacol Exp Ther; 1998 Jul; 286(1):128-35. PubMed ID: 9655851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
    Huuskonen J; Arnala I; Olkkonen H; Alhava E
    Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.
    Adachi JD; Saag KG; Delmas PD; Liberman UA; Emkey RD; Seeman E; Lane NE; Kaufman JM; Poubelle PE; Hawkins F; Correa-Rotter R; Menkes CJ; Rodriguez-Portales JA; Schnitzer TJ; Block JA; Wing J; McIlwain HH; Westhovens R; Brown J; Melo-Gomes JA; Gruber BL; Yanover MJ; Leite MO; Siminoski KG; Nevitt MC; Sharp JT; Malice MP; Dumortier T; Czachur M; Carofano W; Daifotis A
    Arthritis Rheum; 2001 Jan; 44(1):202-11. PubMed ID: 11212161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.
    Ding M; Danielsen CC; Hvid I
    Calcif Tissue Int; 2008 Jan; 82(1):77-86. PubMed ID: 18175032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis.
    Murray TM; Ste-Marie LG
    CMAJ; 1996 Oct; 155(7):949-54. PubMed ID: 8837545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
    Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
    Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.